495 related articles for article (PubMed ID: 28304392)
1. Metrics for glycaemic control - from HbA
Kovatchev BP
Nat Rev Endocrinol; 2017 Jul; 13(7):425-436. PubMed ID: 28304392
[TBL] [Abstract][Full Text] [Related]
2. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
3. Beyond HbA
Brown SA; Basu A; Kovatchev BP
Diabet Med; 2019 Jun; 36(6):679-687. PubMed ID: 30848545
[TBL] [Abstract][Full Text] [Related]
4. Characterizing blood glucose variability using new metrics with continuous glucose monitoring data.
Marling CR; Shubrook JH; Vernier SJ; Wiley MT; Schwartz FL
J Diabetes Sci Technol; 2011 Jul; 5(4):871-8. PubMed ID: 21880228
[TBL] [Abstract][Full Text] [Related]
5. Glycemic Variability: Risk Factors, Assessment, and Control.
Kovatchev B
J Diabetes Sci Technol; 2019 Jul; 13(4):627-635. PubMed ID: 30694076
[TBL] [Abstract][Full Text] [Related]
6. Going beyond HbA1c to understand the benefits of advanced diabetes therapies.
Vigersky RA
J Diabetes; 2019 Jan; 11(1):23-31. PubMed ID: 30151979
[TBL] [Abstract][Full Text] [Related]
7. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
[TBL] [Abstract][Full Text] [Related]
9. Prepregnancy care in women with type 1 diabetes improves HbA
Perea V; Giménez M; Amor AJ; Bellart J; Conget I; Vinagre I
Diabetes Res Clin Pract; 2019 Aug; 154():75-81. PubMed ID: 31271810
[TBL] [Abstract][Full Text] [Related]
10. Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay) on glycaemic control in type 1 and type 2 diabetes patients.
Cosson E; Hamo-Tchatchouang E; Dufaitre-Patouraux L; Attali JR; Pariès J; Schaepelynck-Bélicar P
Diabetes Metab; 2009 Sep; 35(4):312-8. PubMed ID: 19560388
[TBL] [Abstract][Full Text] [Related]
11. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Brøsen JMB; Bomholt T; Borg R; Persson F; Pedersen-Bjergaard U
Ugeskr Laeger; 2024 May; 186(20):. PubMed ID: 38808757
[TBL] [Abstract][Full Text] [Related]
13. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
[TBL] [Abstract][Full Text] [Related]
14. Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses.
Monnier L; Colette C; Owens D
Diabetes Metab; 2021 Mar; 47(2):101173. PubMed ID: 32561428
[TBL] [Abstract][Full Text] [Related]
15. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
[TBL] [Abstract][Full Text] [Related]
16. Glycaemic management in diabetes: old and new approaches.
Ceriello A; Prattichizzo F; Phillip M; Hirsch IB; Mathieu C; Battelino T
Lancet Diabetes Endocrinol; 2022 Jan; 10(1):75-84. PubMed ID: 34793722
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain.
García-Lorenzo B; Rivero-Santana A; Vallejo-Torres L; Castilla-Rodríguez I; García-Pérez S; García-Pérez L; Perestelo-Pérez L
J Eval Clin Pract; 2018 Aug; 24(4):772-781. PubMed ID: 29971893
[TBL] [Abstract][Full Text] [Related]
18. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
[TBL] [Abstract][Full Text] [Related]
19. The Glucose Management Indicator: Time to Change Course?
Selvin E
Diabetes Care; 2024 Jun; 47(6):906-914. PubMed ID: 38295402
[TBL] [Abstract][Full Text] [Related]
20. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
